Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Sep;64(3):463–468. doi: 10.1038/bjc.1991.332

A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.

J H Wijsman 1, C J Cornelisse 1, R Keijzer 1, C J van de Velde 1, J H van Dierendonck 1
PMCID: PMC1977640  PMID: 1911185

Abstract

In order to study the growth kinetics of breast tumours during long-term hormonal withdrawal, we developed a transplantable, invasive mammary carcinoma EMR-86 that originated in a female WAG/Olac rat bearing a subcutaneously implanted oestrogen pellet (EP). Outgrowth of transplanted tumours occurs only in the presence of an EP, and metastases are formed in lungs and regional lymph nodes. Subsequent EP removal induces rapid regression. However, tumours do not disappear completely, as small nodules persist. These dormant tumour remnants can be restimulated even after long periods. Because EP-stimulated tumours regressed after treatment with bromocriptine and dormant tumours in non-oestrogenized rats grew out after treatment with perphenazine, prolactin is the major growth-stimulating hormone in this model. Cell kinetics in the growing, regressing and dormant phase were studied by immunocytochemical detection of DNA-incorporated bromodeoxyuridine (BrdUrd) in tissue sections. BrdUrd labelling indices decreased from 21.6 +/- 3.0% to less than 1% within 7 days after EP removal. After prolonged hormonal withdrawal (up to 90 days) BrdUrd-labelled tumour cells could always be demonstrated (range 0.4-0.8%), without a concomitant increase in tumour volume. Additional treatment either with bromocriptine or with ovariectomy could not significantly reduce this residual proliferative activity, as demonstrated by continuous BrdUrd labelling experiments. The results indicate that in vivo dormancy may represent a steady state of cell division and cell loss, rather than an accumulation of cells in a non-cycling G0 state.

Full text

PDF
463

Images in this article

465Figure 2
on p.465

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basset P., Bellocq J. P., Wolf C., Stoll I., Hutin P., Limacher J. M., Podhajcer O. L., Chenard M. P., Rio M. C., Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 1990 Dec 20;348(6303):699–704. doi: 10.1038/348699a0. [DOI] [PubMed] [Google Scholar]
  2. Ben-Jonathan N. Dopamine: a prolactin-inhibiting hormone. Endocr Rev. 1985 Fall;6(4):564–589. doi: 10.1210/edrv-6-4-564. [DOI] [PubMed] [Google Scholar]
  3. Blankenstein M. A., Broerse J. J., de Vries J. B., van den Berg K. J., Knaan S., van der Molen H. J. The effect of subcutaneous administration of oestrogens on plasma oestrogen levels and tumour incidence in female rats. Eur J Cancer. 1977 Dec;13(12):1437–1443. doi: 10.1016/0014-2964(77)90158-x. [DOI] [PubMed] [Google Scholar]
  4. Blankenstein M. A., Broerse J. J., van Zwieten M. J., van der Molen H. J. Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17 beta. Breast Cancer Res Treat. 1984;4(2):137–141. doi: 10.1007/BF01806396. [DOI] [PubMed] [Google Scholar]
  5. Briand P. Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review). Anticancer Res. 1983 Jul-Aug;3(4):273–281. [PubMed] [Google Scholar]
  6. Briand P., Rose C., Thorpe S. M. Spontaneous regrowth of regressed hormone-dependent tumours after long periods of time. Eur J Cancer Clin Oncol. 1982 Dec;18(12):1391–1393. doi: 10.1016/0277-5379(82)90145-6. [DOI] [PubMed] [Google Scholar]
  7. Cutts J. H., Froude G. C. Regression of estrone-induced mammary tumors in the rat. Cancer Res. 1968 Dec;28(12):2413–2418. [PubMed] [Google Scholar]
  8. Dethlefsen L. A., Prewitt J. M., Mendelsohn M. L. Analysis of tumor growth curves. J Natl Cancer Inst. 1968 Feb;40(2):389–405. doi: 10.1093/jnci/40.2.389. [DOI] [PubMed] [Google Scholar]
  9. Ferguson D. J., Anderson T. J. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br J Cancer. 1981 Aug;44(2):177–181. doi: 10.1038/bjc.1981.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gullino P. M., Grantham F. H., Losonczy I., Berghoffer B. Mammary tumor regression. I. Physiopathologic characteristics of hormone-dependent tissue. J Natl Cancer Inst. 1972 Nov;49(5):1333–1348. [PubMed] [Google Scholar]
  11. Huseby R. A. Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression. Cancer Res. 1983 Nov;43(11):5365–5378. [PubMed] [Google Scholar]
  12. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972 Aug;26(4):239–257. doi: 10.1038/bjc.1972.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kitamura Y., Okamoto S., Uchida N., Yamaguchi K., Matsumoto K. Effect of androgen depletion on growth and androgen dependency of Shionogi carcinoma 115. Cancer Res. 1978 Dec;38(12):4711–4716. [PubMed] [Google Scholar]
  14. Koury M. J., Bondurant M. C. Control of red cell production: the roles of programmed cell death (apoptosis) and erythropoietin. Transfusion. 1990 Oct;30(8):673–674. doi: 10.1046/j.1537-2995.1990.30891020321.x. [DOI] [PubMed] [Google Scholar]
  15. Kyprianou N., English H. F., Davidson N. E., Isaacs J. T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 1991 Jan 1;51(1):162–166. [PubMed] [Google Scholar]
  16. Lancaster S., English H. F., Demers L. M., Manni A. Kinetic and morphometric responses of heterogeneous populations of experimental breast cancer cells in vivo. Cancer Res. 1988 Jun 1;48(11):3276–3281. [PubMed] [Google Scholar]
  17. Lloyd R. V. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. Am J Pathol. 1983 Nov;113(2):198–206. [PMC free article] [PubMed] [Google Scholar]
  18. Murai I., Ben-Jonathan N. Acute stimulation of prolactin release by estradiol: mediation by the posterior pituitary. Endocrinology. 1990 Jun;126(6):3179–3184. doi: 10.1210/endo-126-6-3179. [DOI] [PubMed] [Google Scholar]
  19. Noble R. L., Hochachka B. C., King D. Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation. Cancer Res. 1975 Mar;35(3):766–780. [PubMed] [Google Scholar]
  20. Noble R. L., Hoover L. A classification of transplantable tumors in Nb rats controlled by estrogen from dormancy to autonomy. Cancer Res. 1975 Nov;35(11 Pt 1):2935–2941. [PubMed] [Google Scholar]
  21. Noble R. L. Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res. 1977 Jan;37(1):82–94. [PubMed] [Google Scholar]
  22. Rudland P. S., Barraclough R. Stem cells in mammary gland differentiation and cancer. J Cell Sci Suppl. 1988;10:95–114. doi: 10.1242/jcs.1988.supplement_10.8. [DOI] [PubMed] [Google Scholar]
  23. Russo J., Gusterson B. A., Rogers A. E., Russo I. H., Wellings S. R., van Zwieten M. J. Comparative study of human and rat mammary tumorigenesis. Lab Invest. 1990 Mar;62(3):244–278. [PubMed] [Google Scholar]
  24. Shafie S. M., Grantham F. H. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst. 1981 Jul;67(1):51–56. [PubMed] [Google Scholar]
  25. Vindeløv L. L., Christensen I. J., Nissen N. I. Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry. 1983 Mar;3(5):328–331. doi: 10.1002/cyto.990030504. [DOI] [PubMed] [Google Scholar]
  26. Welsch C. W. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. 1985 Aug;45(8):3415–3443. [PubMed] [Google Scholar]
  27. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]
  28. van Dierendonck J. H., Cornelisse C. J., van der Linden P. W., van Putten L. M., van de Velde C. J. Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies. Cancer Res. 1987 Aug 1;47(15):4093–4098. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES